Ignite Creation Date:
2025-12-24 @ 3:34 PM
Ignite Modification Date:
2026-03-26 @ 7:54 PM
Study NCT ID:
NCT00345592
Status:
COMPLETED
Last Update Posted:
2017-03-28
First Post:
2006-06-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients
Sponsor:
Boston Scientific Corporation
Organization:
Study Overview
Official Title:
TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients
Status:
COMPLETED
Status Verified Date:
2017-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TRADE HF
Brief Summary:
Demonstrate the efficacy of the device-based managed therapy to treat atrial tachycardia and fibrillation (AT/AF) in patients with CHF indication for implant of a CRT defibrillator and to demonstrate the advantage of automatic electrical therapy of atrial arrhythmias compared to an in-hospital approach for treatment of symptomatic AT/AF.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: